Literature DB >> 7575116

The association between melanoma, lymphoma, and other primary neoplasms.

J P Riou1, S Ariyan, K R Brandow, L P Fielding.   

Abstract

BACKGROUND AND
OBJECTIVE: Reports of multiple primary tumors are not new. However, we have noted a disproportionate number of patients with melanoma in whom lymphoma develops and wanted to define the incidence of this association.
DESIGN: All 664 patients with melanoma treated at Yale-New Haven Hospital, Conn, during the 5-year period from 1986 to 1991 were reviewed. The incidence of all the associated malignant neoplasms among our patients with melanoma was compared with the incidence that would be expected in the normal population adjusted for age, race, and sex.
RESULTS: Among the 664 patients, 54 (8.1%) had one or more additional malignant neoplasms. Of the 10 different malignant tumor types recorded, lymphomas were the most prevalent. This incidence of lymphoma among the melanoma patients was 12 of 664, resulting in an incidence of 548 per 100,000 population, 16 times higher (P < .0125) than the expected incidence (34 per 100,000) when adjusted for age, sex, and race.
CONCLUSIONS: The incidence of a second malignant neoplasm in our patients with melanoma was 8.1%. Lymphoma was a particularly common type of second malignancy, showing an incidence more than 16-fold higher than that expected in the normal population. It is particularly important, from a clinical point of view, to be aware of this when clinically palpable lymph nodes develop in areas not normally the site of regional lymphatic drainage of the primary melanoma.

Entities:  

Mesh:

Year:  1995        PMID: 7575116     DOI: 10.1001/archsurg.1995.01430100034007

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

Review 1.  Melanoma in immunosuppressed patients.

Authors:  Agnieszka W Kubica; Jerry D Brewer
Journal:  Mayo Clin Proc       Date:  2012-10       Impact factor: 7.616

2.  A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma.

Authors:  Jeffrey M Farma; Jonathan S Zager; Victor Barnica-Elvir; Christopher A Puleo; Suroosh S Marzban; Dana E Rollison; Jane L Messina; Vernon K Sondak
Journal:  Ann Surg Oncol       Date:  2012-11-20       Impact factor: 5.344

3.  Melanoma and mantle cell lymphoma in a single collision tumor.

Authors:  Madhuri Badrinath; Ajay Tambe; Poornima Ramadas; Melissa Mahajan; Adham Jurdi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-07-30

4.  Synchronously diagnosed lymph nodal collision tumor of malignant melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: case report.

Authors:  Dina El Demellawy; Catherine Ross; Monalisa Sur; Salem Alowami
Journal:  Diagn Pathol       Date:  2007-08-30       Impact factor: 2.644

5.  Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland.

Authors:  D B McKenna; D Stockton; D H Brewster; V R Doherty
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

6.  Concurrent malignant melanoma and cutaneous involvement by classical Hodgkin lymphoma (CHL) in a 63 year-old man.

Authors:  Alejandro A Gru; Dongsi Lu
Journal:  Diagn Pathol       Date:  2013-08-09       Impact factor: 2.644

7.  Correlations Between Cutaneous Malignant Melanoma and Other Cancers: An Ecological Study in Forty European Countries.

Authors:  Pablo Fernandez-Crehuet Serrano; Jose Luis Fernandez-Crehuet Serrano; Mohamed Farouk Allam; Rafael Fernandez-Crehuet Navajas
Journal:  Int J Prev Med       Date:  2016-05-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.